Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Affleck Greene McMurtry LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Bureau Remedies Allergan Acquisition
In a consent agreement reached with the Competition Bureau, Teva Pharmaceutical Industries Ltd. has agreed to divest assets related to two pharmaceutical products in order to complete its acquisition of Allergan plc in Canada.
Canada
10 May 2016
2
Competition Bureau Prescribes Remedy for Pfizer-Hospira Deal
Following concerns that Pfizer Inc.'s proposed acquisition of Hospira Inc. will result in a substantial lessening of competition, Pfizer has reached an agreement with the Competition Bureau to sell the Canadian assets related to four pharmaceutical products distributed by the pharma giant in Canada.
Canada
17 Aug 2015
3
GSK-Novartis Transaction Approved In Canada Based On Commitments In EU And US
Although only the OTC joint venture was notifiable under Part IX of the Competition Act, the Bureau conducted a full analysis on all three parts of the proposed transaction.
Worldwide
16 Apr 2015
4
Competition Bureau Approves Pharmacy Management Merger
Pharmacy management solutions companies TELUS Health and XD3 Solutions recently agreed to make it easier for pharmacists to switch software providers.
Canada
3 Feb 2015
5
Competition Bureau Clears Life Sciences Merger
Thermo Fisher Scientific Inc. can proceed with its acquisition of Life Technologies Corporation after the Competition Bureau issued a Nwellwash_versa_rev1013_squareo Action Letter on December 5, 2013, indicating that the Commissioner does not intend to challenge the deal.
Canada
11 Dec 2013
Links to Result pages
 
1